WO2085 Moisturising Cream

DEVICE2 trials

Sponsors

Dr. August Wolff GmbH & Co. KG Arzneimittel

Conditions

Vulvovaginal Atrophy

Phase 4

Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol

CompletedNCT03044652

Dr. August Wolff GmbH & Co. KG ArzneimittelVulvovaginal Atrophy

Start: 2016-11-30End: 2017-06-30Updated: 2017-07-14

Unknown Phase

Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal Dryness

CompletedNCT03593122

Dr. August Wolff GmbH & Co. KG ArzneimittelVulvovaginal Atrophy

Start: 2010-01-04End: 2010-07-31Updated: 2018-07-19